QUODD

Insider Transactions last 24 months for Neurogene Inc. - NSDQ: NGNE

Transactions
All	Buy	Sell	Option Exercise

Filer's Name	Relationship/ Title	Trans. Date	Trans. Type	Ownership Type	Security Type	Shares	Price	Trans. Value	Total Shares Owned
Cobb Stuart	Chief Scientific Officer	05/14/2025	DS	Direct	COM	6,797	$15.15	$103,003.10	20,794
Mcminn Rachel	Chief Executive Officer	03/26/2025	AA	Direct	COM	23,900	$0.00	$0.00	1,274,259
Jordan Julie	Chief Medical Officer	03/26/2025	AA	Direct	COM	8,400	$0.00	$0.00	8,400
Cvijic Christine Mikail	President and CFO	03/26/2025	AA	Direct	COM	20,300	$0.00	$0.00	92,643
Cobb Stuart	Chief Scientific Officer	03/26/2025	AA	Direct	COM	7,200	$0.00	$0.00	27,591
Cvijic Christine Mikail	President and CFO	03/13/2025	DS	Direct	COM	4,501	$16.94	$76,246.94	72,343
Samsara Biocapital Gp, Llc	Other	11/26/2024	AP	Indirect	COM	2,000	$27.50	$55,000.00	1,717,127
Samsara Biocapital Gp, Llc	Other	11/26/2024	AP	Indirect	COM	15,219	$26.73	$406,803.87	1,715,127
Samsara Biocapital Gp, Llc	Other	11/26/2024	AP	Indirect	COM	10,803	$26.01	$280,986.03	1,699,908
Samsara Biocapital Gp, Llc	Other	11/26/2024	AP	Indirect	COM	20,748	$24.91	$516,832.68	1,689,105
Mcminn Rachel	Chief Executive Officer	11/22/2024	AP	Direct	COM	47,500	$20.40	$969,000.00	1,297,859
Cvijic Christine Mikail	President and CFO	11/22/2024	AP	Direct	COM	24,000	$20.48	$491,400.00	76,844
Cobb Stuart	Chief Scientific Officer	03/13/2024	AA	Direct	COM	20,391	$0.00	$0.00	20,391
Cvijic Christine Mikail	President and CFO	03/13/2024	AA	Direct	COM	31,903	$0.00	$0.00	52,844

1 You are at page 1 of 1 pages

Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security \| D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) \| E = Expiration of short derivative position \| F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. \| G = Gift \| H = Expiration (or cancellation) of long derivative position with value received \| I = Discretionary transaction in accordance with Rule 16b-3(f) \| J = Other \| L = Small acquisition under Rule 16a-6 \| M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 \| O = Exercise of out-of-the-money derivative security \| P = Open market or private purchase \| S = Open market or private sale \| U = Disposition pursuant to a tender of shares in a change of control transaction \| W = Acquisition or disposition by will or the laws of descent and distribution \| X = Exercise of in-the-money or at-the-money derivative security \| Z = Deposit into or withdrawal from voting trust		Send to Excel

Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust

Send to Excel